TCL Archive New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years October 26, 2012
TCL Archive Professional societies: ACCC honors Clinton For Cancer Drug Initiatives, Insurance Bill September 27, 1996
TCL Archive In Brief: Hammer Reappointed chairman; Wyngaarden Names Ferguson of Baylor As OMAR Director July 29, 1988
TCL Archive Also in This 8-page Issue: In Overhaul of Ethics Rules, NIH Bans Employees From Consulting for and Owning Stock in Biomedical Companies. February 4, 2005
